Literature DB >> 23917077

Cancer-promoting role of adipocytes in asbestos-induced mesothelial carcinogenesis through dysregulated adipocytokine production.

Shan Hwu Chew1, Yasumasa Okazaki, Hirotaka Nagai, Nobuaki Misawa, Shinya Akatsuka, Kyoko Yamashita, Li Jiang, Yoriko Yamashita, Michio Noguchi, Kiminori Hosoda, Yoshitaka Sekido, Takashi Takahashi, Shinya Toyokuni.   

Abstract

Like many other human cancers, the development of malignant mesothelioma is closely associated with a chronic inflammatory condition. Both macrophages and mesothelial cells play crucial roles in the inflammatory response caused by asbestos exposure. Here, we show that adipocytes can also contribute to asbestos-induced inflammation through dysregulated adipocytokine production. 3T3-L1 preadipocytes were differentiated into mature adipocytes prior to use. These cells took up asbestos fibers (chrysotile, crocidolite and amosite) but were more resistant to asbestos-induced injury than macrophages and mesothelial cells. Expression microarray analysis followed by reverse transcription-PCR revealed that adipocytes respond directly to asbestos exposure with an increased production of proinflammatory adipocytokines [e.g. monocyte chemoattractant protein-1 (MCP-1)], whereas the production of anti-inflammatory adipocytokines (e.g. adiponectin) is suppressed. This was confirmed in epididymal fat pad of mice after intraperitoneal injection of asbestos fibers. Such dysregulated adipocytokine production favors the establishment of a proinflammatory environment. Furthermore, MCP-1 marginally promoted the growth of MeT-5A mesothelial cells and significantly enhanced the wound healing of Y-MESO-8A and Y-MESO-8D human mesothelioma cells. Our results suggest that increased levels of adipocytokines, such as MCP-1, can potentially contribute to the promotion of mesothelial carcinogenesis through the enhanced recruitment of inflammatory cells as well as a direct growth and migration stimulatory effect on mesothelial and mesothelioma cells. Taken together, our findings support a potential cancer-promoting role of adipocytes in asbestos-induced mesothelial carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23917077     DOI: 10.1093/carcin/bgt267

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  9 in total

Review 1.  Iron overload as a major targetable pathogenesis of asbestos-induced mesothelial carcinogenesis.

Authors:  Shinya Toyokuni
Journal:  Redox Rep       Date:  2013-11-20       Impact factor: 4.412

Review 2.  Stromal contributions to the carcinogenic process.

Authors:  Mark Spaw; Shrikant Anant; Sufi Mary Thomas
Journal:  Mol Carcinog       Date:  2016-11-05       Impact factor: 4.784

3.  Characterization of increasing stages of invasiveness identifies stromal/cancer cell crosstalk in rat models of mesothelioma.

Authors:  Joëlle S Nader; Jérôme Abadie; Sophie Deshayes; Alice Boissard; Stéphanie Blandin; Christophe Blanquart; Nicolas Boisgerault; Olivier Coqueret; Catherine Guette; Marc Grégoire; Daniel L Pouliquen
Journal:  Oncotarget       Date:  2018-03-27

4.  Connective tissue growth factor produced by cancer‑associated fibroblasts correlates with poor prognosis in epithelioid malignant pleural mesothelioma.

Authors:  Yuuki Ohara; Atsushi Enomoto; Yuta Tsuyuki; Kotaro Sato; Tadashi Iida; Hiroki Kobayashi; Yasuyuki Mizutani; Yuki Miyai; Akitoshi Hara; Shinji Mii; Jun Suzuki; Kyoko Yamashita; Fumiya Ito; Yashiro Motooka; Nobuaki Misawa; Takayuki Fukui; Koji Kawaguchi; Kohei Yokoi; Shinya Toyokuni
Journal:  Oncol Rep       Date:  2020-07-03       Impact factor: 3.906

Review 5.  Roles of omental and bone marrow adipocytes in tumor biology.

Authors:  Yoon Jin Cha; Ja Seung Koo
Journal:  Adipocyte       Date:  2019-12       Impact factor: 4.534

6.  A molecular targeting against nuclear factor-κB, as a chemotherapeutic approach for human malignant mesothelioma.

Authors:  Sho Nishikawa; Akane Tanaka; Akira Matsuda; Kumiko Oida; Hyosun Jang; Kyungsook Jung; Yosuke Amagai; Ginae Ahn; Noriko Okamoto; Saori Ishizaka; Hiroshi Matsuda
Journal:  Cancer Med       Date:  2014-02-10       Impact factor: 4.452

7.  Urokinase-type plasminogen activator receptor promotes proliferation and invasion with reduced cisplatin sensitivity in malignant mesothelioma.

Authors:  Shenqi Wang; Li Jiang; Yipeng Han; Shan Hwu Chew; Yuuki Ohara; Shinya Akatsuka; Liang Weng; Koji Kawaguchi; Takayuki Fukui; Yoshitaka Sekido; Kohei Yokoi; Shinya Toyokuni
Journal:  Oncotarget       Date:  2016-10-25

8.  Connective tissue growth factor-specific monoclonal antibody inhibits growth of malignant mesothelioma in an orthotopic mouse model.

Authors:  Yuuki Ohara; Shan Hwu Chew; Nobuaki Misawa; Shenqi Wang; Daiki Somiya; Kae Nakamura; Hiroaki Kajiyama; Fumitaka Kikkawa; Yuta Tsuyuki; Li Jiang; Kyoko Yamashita; Yoshitaka Sekido; Kenneth E Lipson; Shinya Toyokuni
Journal:  Oncotarget       Date:  2018-04-06

9.  Curated gene expression dataset of differentiating 3T3-L1 adipocytes under pharmacological and genetic perturbations.

Authors:  Mahmoud Ahmed; Do Sik Min; Deok Ryong Kim
Journal:  Adipocyte       Date:  2020-12       Impact factor: 4.534

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.